RBC Capital analyst Arun Viswanathan lowered the firm’s price target on Chemours (CC) to $17 from $19 and keeps an Outperform rating on the shares after its Q3 earnings miss. The stock saw a positive reaction to the quarter but remains down over 25% YTD as pricing pressure remains in TiO2, and operational upsets in Advanced Performance Materials are offsetting gains in Thermal & Specialized Solutions, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC: